Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 11—November 2010

Dispatch

Isolation of Ancestral Sylvatic Dengue Virus Type 1, Malaysia

Boon-Teong Teoh, Sing-Sin Sam, Juraina Abd-Jamil, and Sazaly AbuBakarComments to Author 
Author affiliations: University of Malaya, Kuala Lumpur, Malaysia

Main Article

Table 2

Serum neutralization of ancestral sylvatic dengue virus isolate D1/Malaysia/36046/05, Malaysia*

Serum group* Neutralizing antibody titer†
Mock 0
Virus 0
Medium 0
SI 320
SII 80

*Mock, controls treated with serum from healthy (no dengue infection) donors; virus, virus plus diluent; medium, serum and diluent without virus; SI, subgenotype I; SII, subgenotype II.
†Reciprocal of the highest serum dilution that reduced viral foci by 50% (50% focus-reduction neutralization test). Serum from patients infected with sylvatic virus was not available. Virus was treated with serum from patients infected with primary dengue virus type 1 SI or SII.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO